immune B cell and plasma cell depleting CAR T-cell therapy (Penn Medicine)

N/A

Report date: 2025/03/20 15:30:39

Base Information

Drug Nameimmune B cell and plasma cell depleting CAR T-cell therapy (Penn Medicine)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionB-lymphocyte inhibitors

TargetsUpdating

Therapy Area/IndicationsRejection of renal transplantation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsYes

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPenn Medicine

China Registration ClassN/A

Develop Information

Active CompaniesPenn Medicine

Inactive CompaniesN/A

Active IndicationsRejection of renal transplantation

Inactive IndicationsN/A

Other Information

ATC CodeN/A